Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Scaled Net Operating Assets : 0.81 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's operating assets for the quarter that ended in Mar. 2024 was E£3,019 Mil. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's operating liabilities for the quarter that ended in Mar. 2024 was E£418 Mil. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Total Assets for the quarter that ended in Dec. 2023 was E£3,218 Mil. Therefore, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.81.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Scaled Net Operating Assets Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Scaled Net Operating Assets Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.95

0.86

0.77

0.83

0.92

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.74	0.80	0.79	0.78	0.81

Competitive Comparison of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Scaled Net Operating Assets falls into.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(2905.018	-	366.044)	/	2773.031
=	0.92

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3218.272	-	313.254
=	2905.018

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1442.773	-	11.7	-	1065.029
=	366.044

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(3018.833	-	417.674)	/	3218.272
=	0.81

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3361.485	-	342.652
=	3018.833

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1525.843	-	8.904	-	1099.265
=	417.674

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY

Website

https://www.ramedapharma.com

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. It is engaged in the manufacture and sale of branded generic pharmaceutical products nutraceuticals, cosmeceuticals, food supplements, medical devices, and veterinary products. The firm is engaged in therapeutic areas namely systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system, nervous system, and blood and blood-forming organs.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Headlines

No Headlines